
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein is a well-established and diversified company with a strong presence in the dental, medical, and specialty products segments, but faces competition and challenges in the dental industry. While their focus on improving growth and margins is promising, external factors such as high costs and limited insurance coverage may impact their success. Other players in the market, such as Medline, Inc. and Omnicell, Inc., may also present competition and potential risks. However, HSIC's positive financial performance and potential for growth make it an attractive investment opportunity.
Bears say
Henry Schein is focused on growth and margin expansion, investing in acquisitions and new business opportunities, with a concentration on high-margin, high-growth businesses. The company has a strong leadership team, with CEO Mr. Frederick M. Lowery bringing extensive experience in distribution and product businesses. However, there are risks, such as potential disruptions or headwinds, competition from larger competitors with more resources, and potential industry consolidation. Additionally, while the global dental market is durable, current growth projections for Henry Schein in 2026E may be fairly low compared to its potential and its leading market position.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares